Veklury (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin content

Kovács, TamásKurtán, KittiVarga, ZoltánNagy, PéterPanyi, GyörgyZákány, Florina2023-04-142023-04-142023British Journal Of Pharmacology. -180 : 16 (2023), p. 2064-2084. -Br. J. Pharmacol. - 0007-11880007-1188https://hdl.handle.net/2437/349481Veklury (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin contentfolyóiratcikkopen access articlehttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM110635OrvostudományokElméleti orvostudományokhttps://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.16063szerzőhttp://dx.doi.org/10.1111/bph.160632023-04-1400098507210000185151447550